GeneDx is trading 7.69% up in after-hours at $60.47, with no clear catalyst established for the rebound.
- The shares closed at $56.15 on October 23, 2026, after falling 16.37% during that regular session.
- GeneDx announced new Seattle Children’s study data on October 23, but available reporting does not link it to the price move.
- Recent coverage also included a law firm’s investigation announcement, with no evidence explaining the rebound.